post-add

Articles for Finance

Alembic Pharmaceuticals Revenues Grow By 17.7%, PAT At 121 Cr In Q1 Results

Alembic's Profit After Tax (PAT) was recorded at Rs 121 crores in Q1FY24 against a net loss of Rs 86 crores in the same quarter last year whereas the profits dipped by 21 per cent quarter on quarter (QoQ) compared with Rs 153 crores recorded in the March quarter

Read More
Piramal Pharma Records Net Loss Of Rs 99 Cr In Q1FY24

Piramal Pharma recorded a net loss of Rs 99 crore against a net loss of Rs 109 crore recorded in the corresponding quarter of the previous year

Read More
Q1 Results: Lupin Reports Net Profit Of Rs 452 Cr, Sales Grow By 31.6%

Pharma major Lupin on Thursday reported its financial performance for the quarter ending June 30, 2023. The company has registered a rise of 31.6 per cent year on year in its revenue from operations to be recorded at Rs 4,742 crores in Quarter One of Financial Year 2024 (Q1FY24) up from Rs 3,743 crores in the corresponding quarter last year

Read More
Sun Pharma's Profit Falls By 1.8%, Sales Grow By 10.7% YoY In Q1FY24

Sun Pharma's Profit After Tax (PAT) fell by 1.8 per cent YoY to Rs 2,022 crores against Rs 2,060 crores in the corresponding quarter of the previous year.

Read More
Narayana Hrudayalaya's Profit Hikes By 66.4% YoY In Q1 Results

Narayana Hrudayalaya, a leading healthcare service provider in India on Wednesday announced its financial results for the first quarter (Q1 FY24) ended June 30, 2023. The healthcare provider recorded its consolidated revenue at Rs 1,233 crores for Q1 FY24 as compared to Rs 1,033 crores in the corresponding period of the previous year, reflecting an increase of 19.4 per cent YoY and 1.0 per cent QoQ

Read More
Mankind Pharma's PAT Surges By 66% YoY In Q1FY24

Mankind Pharma's net profit jumped by a whopping 66 per cent year on year (YoY) in Q1FY24, the company recorded a net profit of Rs 494 crores in the June quarter. The company saw an increase of Rs 196 crores from the earnings of the same quarter last year which stood at Rs 298 crores

Read More
Concord Biotech IPO To Open On 04 Aug At Rs 705 To Rs 741 Per Share

Ahmedabad-based Concord Biotech has fixed the price band at Rs 705 to Rs 741 per Equity Share for its maiden public offer. The initial public offering of the company will open on Friday, 4th August, 2023, for subscription and will close on Tuesday, 8th August 2023. Investors can bid for a minimum of 20 Equity Shares and in multiples of 20 Equity Shares thereafter

Read More
Syngene Revenue Up 26% To Rs 832 crores, PAT Up 26% In Q1FY24

Syngene International on Wednesday announced its first quarter results. The company's quarterly revenue was up 26 per cent year-on-year to Rs. 832 crores, while profit after tax for the quarter increased 26 per cent year-on-year to Rs 93 crores

Read More

Subscribe to our newsletter to get updates on our latest news